Denmark has stopped vaccinating with a product from AstraZeneca. According to the Director of Health of the Kingdom, the vaccine Vaxzevria will not be used due to the identified cases of blood clots.
The local media write that refusal of the drug will cause a delay in vaccination.
However, the European Medicines Agency stated that the benefits of using the Vaxzevria vaccine outweigh the risks associated with it. The regulator will list thrombosis as a rare side effect.